Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Bipolar Disorder | 82 | 2018 | 5128 | 4.970 |
Why?
|
United States Department of Veterans Affairs | 28 | 2020 | 937 | 3.870 |
Why?
|
Mental Health Services | 26 | 2020 | 1729 | 3.470 |
Why?
|
Patient Care Team | 13 | 2020 | 2517 | 2.700 |
Why?
|
Cooperative Behavior | 22 | 2020 | 1512 | 2.650 |
Why?
|
Veterans | 32 | 2020 | 2667 | 2.330 |
Why?
|
Mental Disorders | 26 | 2020 | 6871 | 2.270 |
Why?
|
Antipsychotic Agents | 19 | 2018 | 3077 | 2.000 |
Why?
|
Antimanic Agents | 8 | 2016 | 523 | 1.230 |
Why?
|
Models, Organizational | 7 | 2020 | 548 | 1.170 |
Why?
|
Health Plan Implementation | 5 | 2019 | 337 | 1.150 |
Why?
|
Self Care | 14 | 2016 | 800 | 1.130 |
Why?
|
Long-Term Care | 5 | 2019 | 630 | 1.000 |
Why?
|
Primary Health Care | 11 | 2019 | 4736 | 0.970 |
Why?
|
Mood Disorders | 7 | 2019 | 1127 | 0.950 |
Why?
|
Interprofessional Relations | 3 | 2018 | 998 | 0.930 |
Why?
|
Community Mental Health Services | 9 | 2019 | 386 | 0.900 |
Why?
|
Hospitals, Veterans | 6 | 2019 | 395 | 0.830 |
Why?
|
Organizational Innovation | 4 | 2020 | 540 | 0.790 |
Why?
|
Delivery of Health Care, Integrated | 5 | 2013 | 949 | 0.790 |
Why?
|
Patient-Centered Care | 5 | 2019 | 1447 | 0.720 |
Why?
|
Evidence-Based Practice | 4 | 2019 | 499 | 0.710 |
Why?
|
Off-Label Use | 3 | 2017 | 185 | 0.700 |
Why?
|
Disease Management | 5 | 2019 | 2531 | 0.680 |
Why?
|
Stress Disorders, Post-Traumatic | 9 | 2017 | 4627 | 0.670 |
Why?
|
Quality of Life | 19 | 2019 | 13468 | 0.660 |
Why?
|
United States | 54 | 2020 | 72920 | 0.650 |
Why?
|
Quality of Health Care | 10 | 2019 | 4306 | 0.630 |
Why?
|
Diffusion of Innovation | 3 | 2015 | 723 | 0.620 |
Why?
|
Evidence-Based Medicine | 7 | 2019 | 3690 | 0.580 |
Why?
|
Self Report | 3 | 2019 | 3769 | 0.580 |
Why?
|
Mentally Ill Persons | 1 | 2018 | 124 | 0.580 |
Why?
|
Telecommunications | 1 | 2017 | 79 | 0.550 |
Why?
|
Psychiatric Status Rating Scales | 17 | 2019 | 6020 | 0.550 |
Why?
|
Telemedicine | 5 | 2020 | 3108 | 0.540 |
Why?
|
Health Status | 8 | 2017 | 4086 | 0.540 |
Why?
|
Comparative Effectiveness Research | 4 | 2016 | 713 | 0.540 |
Why?
|
Psychiatry | 7 | 2019 | 1715 | 0.510 |
Why?
|
Love | 1 | 2016 | 39 | 0.510 |
Why?
|
Health Services Research | 9 | 2020 | 1811 | 0.500 |
Why?
|
Suicide | 6 | 2014 | 1606 | 0.500 |
Why?
|
Program Development | 6 | 2019 | 1297 | 0.500 |
Why?
|
Medication Therapy Management | 1 | 2016 | 131 | 0.490 |
Why?
|
Chronic Disease | 10 | 2019 | 9354 | 0.480 |
Why?
|
Psychometrics | 6 | 2019 | 3060 | 0.480 |
Why?
|
Videoconferencing | 2 | 2020 | 209 | 0.470 |
Why?
|
Multicenter Studies as Topic | 2 | 2019 | 1729 | 0.470 |
Why?
|
Middle Aged | 80 | 2020 | 223083 | 0.460 |
Why?
|
Personal Satisfaction | 2 | 2018 | 641 | 0.460 |
Why?
|
Adult | 78 | 2020 | 223139 | 0.450 |
Why?
|
Employment | 3 | 2013 | 1108 | 0.450 |
Why?
|
Cardiovascular Diseases | 11 | 2017 | 15647 | 0.440 |
Why?
|
Male | 97 | 2020 | 363935 | 0.440 |
Why?
|
Behavioral Research | 1 | 2013 | 52 | 0.430 |
Why?
|
Physicians, Primary Care | 2 | 2017 | 622 | 0.430 |
Why?
|
Computers | 1 | 2016 | 588 | 0.430 |
Why?
|
Self-Injurious Behavior | 1 | 2019 | 572 | 0.430 |
Why?
|
Behavior Control | 1 | 2013 | 46 | 0.430 |
Why?
|
Humans | 133 | 2020 | 766117 | 0.410 |
Why?
|
Single-Blind Method | 5 | 2019 | 1588 | 0.410 |
Why?
|
Science | 1 | 2015 | 234 | 0.410 |
Why?
|
Schizophrenia | 9 | 2017 | 6975 | 0.410 |
Why?
|
Female | 96 | 2020 | 396233 | 0.400 |
Why?
|
Attitude to Health | 5 | 2009 | 2020 | 0.400 |
Why?
|
Health Services Accessibility | 13 | 2016 | 5510 | 0.400 |
Why?
|
Ambulatory Care Facilities | 4 | 2020 | 937 | 0.390 |
Why?
|
Cardiac Care Facilities | 1 | 2011 | 35 | 0.380 |
Why?
|
Comorbidity | 19 | 2018 | 10579 | 0.380 |
Why?
|
Interdisciplinary Communication | 2 | 2017 | 931 | 0.380 |
Why?
|
Goals | 2 | 2014 | 717 | 0.370 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 368 | 0.370 |
Why?
|
Valproic Acid | 3 | 2016 | 444 | 0.360 |
Why?
|
Polypharmacy | 1 | 2013 | 307 | 0.350 |
Why?
|
Depression | 14 | 2019 | 8230 | 0.350 |
Why?
|
Clozapine | 2 | 2013 | 509 | 0.340 |
Why?
|
Knowledge Bases | 1 | 2010 | 96 | 0.340 |
Why?
|
Patient Care Planning | 4 | 2015 | 903 | 0.330 |
Why?
|
Professional-Patient Relations | 5 | 2009 | 723 | 0.330 |
Why?
|
Quality Improvement | 7 | 2019 | 3849 | 0.330 |
Why?
|
Suicide, Attempted | 6 | 2008 | 1413 | 0.330 |
Why?
|
Quinolones | 1 | 2012 | 389 | 0.320 |
Why?
|
Psychotic Disorders | 5 | 2013 | 3274 | 0.310 |
Why?
|
Guideline Adherence | 4 | 2010 | 2235 | 0.310 |
Why?
|
Patient Preference | 1 | 2016 | 947 | 0.300 |
Why?
|
Qualitative Research | 6 | 2020 | 3138 | 0.300 |
Why?
|
Patient Compliance | 6 | 2009 | 2694 | 0.290 |
Why?
|
Research Design | 4 | 2019 | 6206 | 0.290 |
Why?
|
Patient Care Management | 3 | 2016 | 301 | 0.280 |
Why?
|
Drug Therapy, Combination | 3 | 2016 | 6309 | 0.280 |
Why?
|
Behavior Therapy | 2 | 2012 | 886 | 0.270 |
Why?
|
Residence Characteristics | 1 | 2016 | 2116 | 0.270 |
Why?
|
Biomedical Research | 2 | 2019 | 3458 | 0.270 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2019 | 10380 | 0.270 |
Why?
|
Peer Review, Research | 2 | 2006 | 342 | 0.250 |
Why?
|
Quality Indicators, Health Care | 3 | 2016 | 1804 | 0.250 |
Why?
|
Practice Guidelines as Topic | 6 | 2014 | 7424 | 0.250 |
Why?
|
Patient Education as Topic | 7 | 2018 | 2332 | 0.240 |
Why?
|
Patient Selection | 2 | 2014 | 4249 | 0.240 |
Why?
|
Paroxetine | 1 | 2006 | 181 | 0.240 |
Why?
|
Review Literature as Topic | 1 | 2006 | 297 | 0.240 |
Why?
|
Clinical Trials as Topic | 2 | 2019 | 8038 | 0.240 |
Why?
|
Cost of Illness | 3 | 2017 | 1949 | 0.230 |
Why?
|
Physician-Patient Relations | 2 | 2016 | 3270 | 0.230 |
Why?
|
Program Evaluation | 5 | 2019 | 2502 | 0.230 |
Why?
|
Therapy, Computer-Assisted | 2 | 2019 | 265 | 0.230 |
Why?
|
Aged | 24 | 2020 | 171219 | 0.220 |
Why?
|
Geriatrics | 1 | 2008 | 394 | 0.220 |
Why?
|
Substance-Related Disorders | 5 | 2009 | 4418 | 0.210 |
Why?
|
Health Care Reform | 1 | 2012 | 1257 | 0.210 |
Why?
|
Delivery of Health Care | 3 | 2016 | 5367 | 0.210 |
Why?
|
Disease | 1 | 2008 | 674 | 0.210 |
Why?
|
Clinical Competence | 2 | 2016 | 4859 | 0.210 |
Why?
|
Overweight | 1 | 2014 | 2444 | 0.210 |
Why?
|
Liver Failure, Acute | 1 | 2005 | 183 | 0.210 |
Why?
|
Anxiety Disorders | 4 | 2016 | 2741 | 0.210 |
Why?
|
Exercise | 2 | 2017 | 5939 | 0.200 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2006 | 490 | 0.200 |
Why?
|
Antidepressive Agents | 4 | 2016 | 2901 | 0.200 |
Why?
|
Cross-Sectional Studies | 20 | 2017 | 26290 | 0.200 |
Why?
|
Mental Health | 4 | 2019 | 3273 | 0.200 |
Why?
|
Dementia | 1 | 2017 | 2741 | 0.200 |
Why?
|
Piperazines | 1 | 2012 | 2547 | 0.200 |
Why?
|
Logistic Models | 9 | 2019 | 13273 | 0.190 |
Why?
|
Factor Analysis, Statistical | 2 | 2018 | 1001 | 0.190 |
Why?
|
Faculty, Medical | 1 | 2010 | 1225 | 0.190 |
Why?
|
Conflict of Interest | 1 | 2006 | 556 | 0.190 |
Why?
|
Lithium Carbonate | 3 | 2008 | 179 | 0.190 |
Why?
|
Insurance Claim Review | 2 | 2019 | 744 | 0.190 |
Why?
|
Self-Assessment | 1 | 2003 | 401 | 0.180 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 7 | 2010 | 1988 | 0.170 |
Why?
|
Patient Satisfaction | 7 | 2017 | 3477 | 0.170 |
Why?
|
Psychotherapy | 4 | 2018 | 1648 | 0.170 |
Why?
|
Continuity of Patient Care | 5 | 2009 | 1075 | 0.170 |
Why?
|
Case Management | 3 | 2006 | 276 | 0.170 |
Why?
|
Ambulatory Care | 4 | 2019 | 2778 | 0.160 |
Why?
|
Anticonvulsants | 3 | 2006 | 1920 | 0.150 |
Why?
|
Alcoholism | 4 | 2005 | 1979 | 0.150 |
Why?
|
Interinstitutional Relations | 2 | 2012 | 235 | 0.150 |
Why?
|
United States Substance Abuse and Mental Health Services Administration | 1 | 2018 | 21 | 0.150 |
Why?
|
Community Health Services | 2 | 2016 | 657 | 0.150 |
Why?
|
Comprehensive Health Care | 1 | 2019 | 123 | 0.150 |
Why?
|
Severity of Illness Index | 11 | 2014 | 15882 | 0.150 |
Why?
|
Treatment Outcome | 17 | 2018 | 65219 | 0.150 |
Why?
|
Empirical Research | 1 | 2018 | 119 | 0.140 |
Why?
|
Academic Medical Centers | 1 | 2008 | 2782 | 0.140 |
Why?
|
Prospective Studies | 16 | 2018 | 54812 | 0.140 |
Why?
|
Longitudinal Studies | 9 | 2018 | 14747 | 0.140 |
Why?
|
Space-Time Clustering | 1 | 2016 | 45 | 0.140 |
Why?
|
Statistics as Topic | 3 | 2017 | 2351 | 0.140 |
Why?
|
Alcohol-Related Disorders | 2 | 2009 | 243 | 0.140 |
Why?
|
Coronary Disease | 1 | 2011 | 5919 | 0.140 |
Why?
|
Michigan | 2 | 2019 | 329 | 0.140 |
Why?
|
Triiodothyronine | 1 | 2018 | 493 | 0.130 |
Why?
|
Models, Theoretical | 1 | 2008 | 3561 | 0.130 |
Why?
|
Minority Groups | 4 | 2009 | 1208 | 0.130 |
Why?
|
Follow-Up Studies | 14 | 2018 | 39243 | 0.130 |
Why?
|
Depressive Disorder | 4 | 2017 | 3712 | 0.130 |
Why?
|
Costs and Cost Analysis | 2 | 2020 | 1666 | 0.130 |
Why?
|
Professional Role | 1 | 2019 | 314 | 0.130 |
Why?
|
Risk Reduction Behavior | 2 | 2013 | 1121 | 0.130 |
Why?
|
Socioeconomic Factors | 3 | 2017 | 7843 | 0.120 |
Why?
|
Periodicals as Topic | 1 | 2006 | 1463 | 0.120 |
Why?
|
Attitude of Health Personnel | 4 | 2019 | 3928 | 0.120 |
Why?
|
Community Mental Health Centers | 2 | 2012 | 93 | 0.120 |
Why?
|
Affect | 2 | 2018 | 1494 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2013 | 8525 | 0.120 |
Why?
|
Thyroxine | 1 | 2018 | 665 | 0.120 |
Why?
|
Internet | 3 | 2019 | 3107 | 0.110 |
Why?
|
Inappropriate Prescribing | 1 | 2017 | 211 | 0.110 |
Why?
|
Administrative Personnel | 1 | 2015 | 186 | 0.110 |
Why?
|
Health Care Costs | 4 | 2020 | 3243 | 0.110 |
Why?
|
Waiting Lists | 1 | 2019 | 779 | 0.110 |
Why?
|
Medication Adherence | 3 | 2018 | 2190 | 0.110 |
Why?
|
Pilot Projects | 4 | 2012 | 8724 | 0.110 |
Why?
|
Lithium | 1 | 2016 | 599 | 0.110 |
Why?
|
Diabetes Mellitus | 3 | 2018 | 5889 | 0.110 |
Why?
|
Data Collection | 3 | 2012 | 3318 | 0.110 |
Why?
|
Internship and Residency | 2 | 2011 | 5946 | 0.110 |
Why?
|
Risk Factors | 8 | 2019 | 74857 | 0.110 |
Why?
|
Health Status Disparities | 2 | 2019 | 1878 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20137 | 0.100 |
Why?
|
Reminder Systems | 1 | 2016 | 388 | 0.100 |
Why?
|
Self-Help Groups | 1 | 2014 | 194 | 0.100 |
Why?
|
Disability Evaluation | 3 | 2009 | 1824 | 0.100 |
Why?
|
Trust | 1 | 2017 | 532 | 0.100 |
Why?
|
Hospitalization | 4 | 2020 | 10811 | 0.100 |
Why?
|
Cohort Studies | 8 | 2016 | 41684 | 0.100 |
Why?
|
Time Factors | 9 | 2019 | 40108 | 0.090 |
Why?
|
Social Support | 2 | 2013 | 2190 | 0.090 |
Why?
|
Medical Audit | 1 | 2012 | 454 | 0.090 |
Why?
|
Demography | 5 | 2011 | 1641 | 0.090 |
Why?
|
Public-Private Sector Partnerships | 1 | 2012 | 123 | 0.090 |
Why?
|
Body Mass Index | 3 | 2014 | 13046 | 0.090 |
Why?
|
Interview, Psychological | 3 | 2009 | 811 | 0.090 |
Why?
|
Perception | 1 | 2017 | 1204 | 0.090 |
Why?
|
Mid-Atlantic Region | 1 | 2009 | 24 | 0.080 |
Why?
|
Veterans Health | 1 | 2011 | 216 | 0.080 |
Why?
|
Competency-Based Education | 1 | 2011 | 226 | 0.080 |
Why?
|
International Classification of Diseases | 2 | 2013 | 934 | 0.080 |
Why?
|
Job Satisfaction | 1 | 2013 | 548 | 0.080 |
Why?
|
Nursing Care | 1 | 2009 | 66 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2006 | 0.080 |
Why?
|
Cyclothymic Disorder | 2 | 2008 | 42 | 0.080 |
Why?
|
Interviews as Topic | 2 | 2007 | 2741 | 0.080 |
Why?
|
Outpatients | 1 | 2016 | 1596 | 0.080 |
Why?
|
Specialty Boards | 1 | 2010 | 235 | 0.080 |
Why?
|
Home Nursing | 1 | 2008 | 92 | 0.070 |
Why?
|
Models, Educational | 1 | 2011 | 375 | 0.070 |
Why?
|
Likelihood Functions | 2 | 2008 | 993 | 0.070 |
Why?
|
Regression Analysis | 3 | 2013 | 6324 | 0.070 |
Why?
|
Health Surveys | 4 | 2012 | 4058 | 0.070 |
Why?
|
Leadership | 1 | 2017 | 1394 | 0.070 |
Why?
|
Community-Based Participatory Research | 1 | 2009 | 223 | 0.070 |
Why?
|
Psychotherapy, Group | 2 | 2008 | 417 | 0.070 |
Why?
|
Blood Pressure | 2 | 2014 | 8532 | 0.070 |
Why?
|
Risperidone | 2 | 2006 | 383 | 0.070 |
Why?
|
Accreditation | 1 | 2010 | 476 | 0.070 |
Why?
|
Nurses | 1 | 2016 | 2503 | 0.070 |
Why?
|
Medical History Taking | 1 | 2010 | 779 | 0.070 |
Why?
|
Cost-Benefit Analysis | 4 | 2006 | 5531 | 0.070 |
Why?
|
Personality Inventory | 1 | 2009 | 1019 | 0.070 |
Why?
|
Aged, 80 and over | 5 | 2017 | 59515 | 0.070 |
Why?
|
Documentation | 2 | 2010 | 911 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2017 | 81565 | 0.070 |
Why?
|
Registries | 4 | 2012 | 8347 | 0.060 |
Why?
|
Clinical Protocols | 1 | 2012 | 1437 | 0.060 |
Why?
|
Carbamazepine | 1 | 2007 | 224 | 0.060 |
Why?
|
Information Services | 1 | 2007 | 240 | 0.060 |
Why?
|
Pensions | 1 | 2005 | 16 | 0.060 |
Why?
|
Inositol | 1 | 2006 | 215 | 0.060 |
Why?
|
Treatment Refusal | 1 | 2008 | 433 | 0.060 |
Why?
|
Nurse Clinicians | 1 | 2004 | 30 | 0.060 |
Why?
|
Self Disclosure | 1 | 2006 | 249 | 0.060 |
Why?
|
Peer Group | 1 | 2010 | 702 | 0.060 |
Why?
|
Attitude | 1 | 2009 | 768 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2936 | 0.060 |
Why?
|
Hospitals, Psychiatric | 1 | 2005 | 318 | 0.060 |
Why?
|
United States Food and Drug Administration | 1 | 2012 | 1673 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2019 | 22228 | 0.060 |
Why?
|
Medicine | 1 | 2012 | 944 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2865 | 0.060 |
Why?
|
Depressive Disorder, Major | 5 | 2009 | 4809 | 0.060 |
Why?
|
Triazines | 1 | 2006 | 311 | 0.060 |
Why?
|
Drug Prescriptions | 1 | 2013 | 1662 | 0.050 |
Why?
|
Authorship | 1 | 2006 | 289 | 0.050 |
Why?
|
Public Sector | 1 | 2005 | 265 | 0.050 |
Why?
|
Prevalence | 4 | 2014 | 15827 | 0.050 |
Why?
|
Teaching | 1 | 2011 | 1170 | 0.050 |
Why?
|
Antithyroid Agents | 1 | 2003 | 72 | 0.050 |
Why?
|
Combat Disorders | 1 | 2005 | 300 | 0.050 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.050 |
Why?
|
Personality Assessment | 1 | 2005 | 646 | 0.050 |
Why?
|
Complementary Therapies | 1 | 2007 | 486 | 0.050 |
Why?
|
Child Abuse, Sexual | 1 | 2005 | 398 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3909 | 0.050 |
Why?
|
Research Support as Topic | 1 | 2006 | 697 | 0.050 |
Why?
|
Neurology | 1 | 2010 | 784 | 0.050 |
Why?
|
Guidelines as Topic | 1 | 2008 | 1394 | 0.050 |
Why?
|
Young Adult | 2 | 2019 | 59868 | 0.050 |
Why?
|
Activities of Daily Living | 2 | 2009 | 2419 | 0.050 |
Why?
|
Military Personnel | 1 | 2011 | 1260 | 0.050 |
Why?
|
Health Services Needs and Demand | 1 | 2009 | 1404 | 0.050 |
Why?
|
Multivariate Analysis | 3 | 2010 | 12061 | 0.050 |
Why?
|
Hypertension | 2 | 2012 | 8616 | 0.050 |
Why?
|
Reaction Time | 1 | 2007 | 2086 | 0.050 |
Why?
|
California | 1 | 2005 | 1435 | 0.040 |
Why?
|
Drug Monitoring | 1 | 2007 | 961 | 0.040 |
Why?
|
Managed Care Programs | 1 | 2006 | 934 | 0.040 |
Why?
|
Office Visits | 1 | 2005 | 594 | 0.040 |
Why?
|
Lipids | 1 | 2011 | 3316 | 0.040 |
Why?
|
Patient Participation | 1 | 2009 | 1447 | 0.040 |
Why?
|
Linear Models | 1 | 2010 | 5873 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2005 | 1836 | 0.040 |
Why?
|
Curriculum | 2 | 2011 | 3784 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4863 | 0.040 |
Why?
|
Colorado | 1 | 2019 | 167 | 0.040 |
Why?
|
Vulnerable Populations | 1 | 2005 | 717 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2010 | 5300 | 0.040 |
Why?
|
Schizophrenic Psychology | 1 | 2006 | 1646 | 0.040 |
Why?
|
Drug Costs | 1 | 2006 | 1195 | 0.040 |
Why?
|
Intention to Treat Analysis | 1 | 2019 | 418 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1536 | 0.040 |
Why?
|
Pennsylvania | 2 | 2009 | 615 | 0.040 |
Why?
|
Odds Ratio | 1 | 2010 | 9657 | 0.040 |
Why?
|
Thyroid Function Tests | 1 | 2018 | 289 | 0.040 |
Why?
|
Mortality | 1 | 2008 | 2911 | 0.030 |
Why?
|
Blood Glucose | 1 | 2011 | 6421 | 0.030 |
Why?
|
Child Abuse | 1 | 2005 | 1090 | 0.030 |
Why?
|
Emergency Service, Hospital | 1 | 2016 | 7871 | 0.030 |
Why?
|
Thyroid Gland | 1 | 2003 | 1168 | 0.030 |
Why?
|
Informed Consent | 1 | 2002 | 1010 | 0.030 |
Why?
|
ROC Curve | 1 | 2003 | 3614 | 0.030 |
Why?
|
Thyroid Hormones | 1 | 2018 | 408 | 0.030 |
Why?
|
Physicians | 1 | 2013 | 4591 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2004 | 1882 | 0.030 |
Why?
|
Age Factors | 2 | 2009 | 18386 | 0.030 |
Why?
|
Adolescent | 8 | 2009 | 88819 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 2007 | 7119 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2010 | 3407 | 0.030 |
Why?
|
Risk | 1 | 2006 | 9599 | 0.030 |
Why?
|
Pain Measurement | 1 | 2003 | 3576 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7237 | 0.030 |
Why?
|
Health Personnel | 2 | 2006 | 3387 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2008 | 12976 | 0.030 |
Why?
|
Cluster Analysis | 1 | 2019 | 2718 | 0.020 |
Why?
|
Patient Readmission | 1 | 2006 | 3283 | 0.020 |
Why?
|
Panic Disorder | 2 | 2005 | 613 | 0.020 |
Why?
|
Self Efficacy | 1 | 2012 | 641 | 0.020 |
Why?
|
Diagnosis, Dual (Psychiatry) | 1 | 2009 | 300 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2003 | 14645 | 0.020 |
Why?
|
Risk Assessment | 2 | 2008 | 24276 | 0.020 |
Why?
|
Recreation | 1 | 2008 | 124 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2002 | 4054 | 0.020 |
Why?
|
Diabetic Foot | 1 | 2011 | 383 | 0.020 |
Why?
|
Research Personnel | 1 | 2012 | 589 | 0.020 |
Why?
|
Epidemiology | 1 | 2009 | 278 | 0.020 |
Why?
|
Arthritis | 1 | 2012 | 676 | 0.020 |
Why?
|
Predictive Value of Tests | 1 | 2003 | 15403 | 0.020 |
Why?
|
Secondary Prevention | 1 | 2012 | 1470 | 0.020 |
Why?
|
Insurance, Psychiatric | 1 | 2006 | 66 | 0.020 |
Why?
|
Population Surveillance | 2 | 2007 | 2596 | 0.020 |
Why?
|
Washington | 1 | 2006 | 315 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2007 | 527 | 0.020 |
Why?
|
Social Adjustment | 1 | 2007 | 634 | 0.010 |
Why?
|
Mental Status Schedule | 1 | 2005 | 315 | 0.010 |
Why?
|
Patient Dropouts | 1 | 2006 | 411 | 0.010 |
Why?
|
Agoraphobia | 1 | 2004 | 177 | 0.010 |
Why?
|
Family Practice | 1 | 2007 | 508 | 0.010 |
Why?
|
Resource Allocation | 1 | 2006 | 354 | 0.010 |
Why?
|
Personality | 1 | 2008 | 559 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12426 | 0.010 |
Why?
|
Vitamin B Complex | 1 | 2006 | 299 | 0.010 |
Why?
|
Thyrotropin-Releasing Hormone | 1 | 2003 | 139 | 0.010 |
Why?
|
Sex Factors | 2 | 2008 | 10614 | 0.010 |
Why?
|
Psychology | 1 | 2005 | 353 | 0.010 |
Why?
|
Focus Groups | 1 | 2009 | 1459 | 0.010 |
Why?
|
Health Behavior | 1 | 2014 | 2649 | 0.010 |
Why?
|
Research | 1 | 2011 | 1975 | 0.010 |
Why?
|
Anti-Anxiety Agents | 1 | 2004 | 404 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2012 | 2662 | 0.010 |
Why?
|
Indians, North American | 1 | 2005 | 354 | 0.010 |
Why?
|
Benzodiazepines | 1 | 2006 | 1136 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8725 | 0.010 |
Why?
|
Aftercare | 1 | 2006 | 915 | 0.010 |
Why?
|
Age of Onset | 1 | 2007 | 3344 | 0.010 |
Why?
|
Thyrotropin | 1 | 2003 | 834 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4853 | 0.010 |
Why?
|
Early Detection of Cancer | 1 | 2011 | 3238 | 0.010 |
Why?
|
Recovery of Function | 1 | 2006 | 2971 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2004 | 2171 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8494 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2004 | 3719 | 0.000 |
Why?
|
Algorithms | 1 | 2004 | 14066 | 0.000 |
Why?
|
Child | 1 | 2005 | 80573 | 0.000 |
Why?
|